× About the Journal Scope of the Journal SPER Publications Editorial Board Abstracting and Indexing Articles in Press Current Issue Archives Conference Proceedings Submit Article Author Guidelines Advertise Join as Reviewer Contact Publishing Ethics

Year : 2012   |  Volume : 2  |  Issue : 3  |  Page : 93-100

Development and validation of a HPLC analytical assay method for amlodipine besylate tablets: A Potent Ca+2 channel blocker
Amlodipine besylate is a potent calcium channel blocker used for the treatment of hypertension, congestive heart failure and angina pectoris. Amlodipine besylate avoids the adverse effect of amlodipine in racemic mixtures. A highly precise and cost effective RP-HPLC method with retention time of 2.60 minutes was developed for the estimation of amlodipine besylate in tablet dosage form, by fixing the parameters as WATERS C18 column 250 mm × 4.6 mm (5µm), with mobile phase as acetonitrile: 70mM potassium dihydrogen orthophosphate buffer: methanol (15:30:55) and pH adjusted to 3.0 using OPA. Mobile phase flow rate was maintained at 1.0 ml/min and detected at 240nm.
Print this article     Email this article


Contact SPER Publications

SPER Publications and Solutions Pvt. Ltd.

HD - 236,
Near The Shri Ram Millenium School,
Sector 135,
Noida-Greater Noida Expressway,
Noida-201301 [Delhi-NCR] India
Phone: +91-9301907999 / +91-8400033397
E-mail: journals@sperpublications.com
Website: www.sperpublications.com